• 한국소음진동공학회:학술대회논문집
• /
• 한국소음진동공학회 2007년도 추계학술대회논문집
• /
• pp.886-890
• /
• 2007

Machine fault prognosis techniques have been considered profoundly in the recent time due to their profit for reducing unexpected faults or unscheduled maintenance. With those techniques, the working conditions of components, the trending of fault propagation, and the time-to-failure are forecasted precisely before they reach the failure thresholds. In this work, we propose an approach of Least Square Regression Tree (LSRT), which is an extension of the Classification and Regression Tree (CART), in association with one-step-ahead prediction of time-series forecasting technique to predict the future conditions of machines. In this technique, the number of available observations is firstly determined by using Cao's method and LSRT is employed as prognosis system in the next step. The proposed approach is evaluated by real data of low methane compressor. Furthermore, the comparison between the predicted results of CART and LSRT are carried out to prove the accuracy. The predicted results show that LSRT offers a potential for machine condition prognosis.

• 한국멀티미디어학회논문지
• /
• 제16권3호
• /
• pp.269-280
• /
• 2013

본 논문에서 망막 질환 요인간의 의존도 분석을 위해 효율적인 분류기를 활용할 수 있는 방안을 제시하였다. 먼저 여러 베이지안 네트워크 중에서 TAN (Tree-Augmented Naive Bayesian Network), GBN(General Bayesian Network)과 Markov Blanket으로 특징축소된 GBN과의 분류성능과 예측정확률을 비교분석하였다. 그리고 처음으로, 높은 성능을 보인 TAN을 망막 질환 임상데이터의 의존도 분석에 적용하였다. 의존도 분석 결과, 망막 질환의 진단과 예후 예측에 활용의 가능성을 보였다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권1호
• /
• pp.101-105
• /
• 2014

Background and Purpose: Human epididymis protein 4 (HE4) has been suggested to be a novel biomarker of epithelial ovarian cancer (EOC). The present study aimed to evaluate and compare HE4 with the commonly used marker, carbohydrate antigen 125 (CA125), in prediction and therapy-monitoring of EOC. Patients and Methods: Serum HE4 concentrations from 123 ovarian cancer patients and 174 controls were measured by Roche electrochemiluminescent immunoassay (ECLIA). Risk of ovarian malignancy algorithm (ROMA) values were calculated and assessed. In addition, the prospects of HE4 detection for therapy-monitoring were evaluated in EOC patients. Results: The ROMA score could classify patients into high- and low-risk groups with malignancy. Indeed, lower serum HE4 was significantly associated with successful surgical therapy. Specifically, 38 patients with EOC exhibited a greater decline of HE4 compared with CA125. In contrast, elevation of HE4 better predicted recurrence (of 46, 11 patients developed recurrence, and with it increased HE4 serum concentrations) and a poor prognosis than CA125. Conclusions: This study suggests that serum HE4 levels are closely associated with outcome of surgical therapy and disease prognosis in Chinese EOC patients.

• Journal of Oral Medicine and Pain
• /
• 제23권3호
• /
• pp.263-270
• /
• 1998

Considering various factors contributing oral malodor, the accurate prediction of prognosis is very important to both clinician and patients. The present study has been performed to invetigate the relationship between treatment effeicacy and pre-treatment volatile sulfur compounds (VSC) level. Ninety patients were divided into three groups, A(<150ppb), B(150< <200ppb), and C(>200ppb) groups, according to pre-treatment VSC level detected by Halimeter, and each group included 30 patients. Routine therapeutic measures for oral were provided to each patient which consisted of oral prophylaxis, tooth brushing and flossing instruction, tongue scraping by proper device, and gargling of 0.25% ZnCl2 Solution. The group with high pre-treatment VSC level (>150ppb) showed significant reduction of VSC level at 1 and 3 weeks after. However, the group with low pre-treatment VSC level (<150ppb) did not show any significant reduction during the experimental periods. Collectively, the results suggested that patients with high pre-treatment VSC level show better prognosis.

• Korean Journal of Radiology
• /
• 제22권2호
• /
• pp.233-242
• /
• 2021

Objective: To evaluate the association of MRI features with the major genomic profiles and prognosis of World Health Organization grade III (G3) gliomas compared with those of glioblastomas (GBMs). Materials and Methods: We enrolled 76 G3 glioma and 155 GBM patients with pathologically confirmed disease who had pretreatment brain MRI and major genetic information of tumors. Qualitative and quantitative imaging features, including volumetrics and histogram parameters, such as normalized cerebral blood volume (nCBV), cerebral blood flow (nCBF), and apparent diffusion coefficient (nADC) were evaluated. The G3 gliomas were divided into three groups for the analysis: with this isocitrate dehydrogenase (IDH)-mutation, IDH mutation and a chromosome arm 1p/19q-codeleted (IDHmut1p/19qdel), IDH mutation, 1p/19q-nondeleted (IDHmut1p/19qnondel), and IDH wildtype (IDHwt). A prediction model for the genetic profiles of G3 gliomas was developed and validated on a separate cohort. Both the quantitative and qualitative imaging parameters and progression-free survival (PFS) of G3 gliomas were compared and survival analysis was performed. Moreover, the imaging parameters and PFS between IDHwt G3 gliomas and GBMs were compared. Results: IDHmut G3 gliomas showed a larger volume (p = 0.017), lower nCBF (p = 0.048), and higher nADC (p = 0.007) than IDHwt. Between the IDHmut tumors, IDHmut1p/19qdel G3 gliomas had higher nCBV (p = 0.024) and lower nADC (p = 0.002) than IDHmut1p/19qnondel G3 gliomas. Moreover, IDHmut1p/19qdel tumors had the best prognosis and IDHwt tumors had the worst prognosis among G3 gliomas (p < 0.001). PFS was significantly associated with the 95th percentile values of nCBV and nCBF in G3 gliomas. There was no significant difference in neither PFS nor imaging features between IDHwt G3 gliomas and IDHwt GBMs. Conclusion: We found significant differences in MRI features, including volumetrics, CBV, and ADC, in G3 gliomas, according to IDH mutation and 1p/19q codeletion status, which can be utilized for the prediction of genomic profiles and the prognosis of G3 glioma patients. The MRI signatures and prognosis of IDHwt G3 gliomas tend to follow those of IDHwt GBMs.

• Journal of Yeungnam Medical Science
• /
• 제38권4호
• /
• pp.318-325
• /
• 2021

Background: The diagnosis and prediction of prognosis are important in patients with sepsis, and presepsin is helpful. In this study, we aimed to examine the usefulness of presepsin in predicting the prognosis of sepsis in Korea. Methods: Patients diagnosed with sepsis according to the sepsis-3 criteria were recruited into the study and classified into surviving and non-surviving groups based on in-hospital mortality. A total of 153 patients (32 and 121 patients with sepsis and septic shock, respectively) were included from July 2019 to August 2020. Results: Among the 153 patients with sepsis, 91 and 62 were in the survivor and non-survivor groups, respectively. Presepsin (p=0.004) and lactate (p=0.003) levels and the sequential organ failure assessment (SOFA) score (p<0.001) were higher in the non-survivor group. Receiver operating characteristic curve analysis revealed poor performances of presepsin and lactate in predicting the prognosis of sepsis (presepsin: area under the curve [AUC]=0.656, p=0.001; lactate: AUC=0.646, p=0.003). The SOFA score showed the best performance, with the highest AUC value (AUC=0.751, p<0.001). The prognostic cutoff point for presepsin was 1,176 pg/mL. Presepsin levels higher than 1,176 pg/mL (odds ratio [OR], 3.352; p<0.001), higher lactate levels (OR, 1.203; p=0.003), and higher SOFA score (OR, 1.249; p<0.001) were risk factors for in-hospital mortality. Conclusion: Presepsin levels were higher in non-survivors than in survivors. Thus, presepsin may be a valuable biomarker in predicting the prognosis of sepsis.

• Journal of Gastric Cancer
• /
• 제20권4호
• /
• pp.385-394
• /
• 2020

Purpose: Patients with gastric cancer who receive neoadjuvant therapy are staged before treatment (cStage) and after treatment (ypStage). We aimed to compare the prognostic reliability of cStage and ypStage, alone and in combination. Materials and Methods: Data for all patients who received neoadjuvant therapy followed by surgery for gastric adenocarcinoma from 2004 to 2015 were extracted from the National Cancer Database. Kaplan-Meier (KM)curves were used to model overall survival based on cStage alone, ypStage alone, cStage stratified by ypStage, and ypStage stratified by cStage. P-values were generated to summarize the differences in KM curves. The discriminatory power of survival prediction was examined using Harrell's C-statistics. Results: We included 8,977 patients in the analysis. As expected, increasing cStage and ypStage were associated with worse survival. The discriminatory prognostic power provided by cStage was poor (C-statistic 0.548), while that provided by ypStage was moderate (C-statistic 0.634). Within each cStage, the addition of ypStage information significantly altered the prognosis (P<0.0001 within cStages I-IV). However, for each ypStage, the addition of cStage information generally did not alter the prognosis (P=0.2874, 0.027, 0.061, 0.049, and 0.007 within ypStages 0-IV, respectively). The discriminatory prognostic power provided by the combination of cStage and ypStage was similar to that of ypStage alone (C-statistic 0.636 vs. 0.634). Conclusions: The cStage is unreliable for prognosis, and ypStage is moderately reliable. Combining cStage and ypStage does not improve the discriminatory prognostic power provided by ypStage alone. A ypStage-based prognosis is minimally affected by the initial cStage.

• 정보처리학회논문지:소프트웨어 및 데이터공학
• /
• 제8권10호
• /
• pp.397-402
• /
• 2019

암 환자에게 적절한 치료계획을 제공하기 위해 암의 진행양상 또는 환자의 생존 기간 등에 해당하는 환자의 예후를 정확히 예측하는 것은 생물정보학 분야에서 다루는 중요한 도전 과제 중 하나이다. 많은 연구에서 암 환자의 유전자 발현량 데이터를 이용하여 환자의 예후를 예측하는 기계학습 모델들이 많이 제안되어 오고 있다. 유전자 발현량 데이터는 약 17,000개의 유전자에 대한 수치값을 갖는 고차원의 수치형 자료이기에, 기존의 연구들은 특징 선택 또는 차원 축소 전략을 이용하여 예측 모델의 성능 향상을 도모하였다. 그러나 이러한 접근법은 특징 선택과 예측 모델의 훈련이 분리되어 있어서, 기계학습 모델은 선별된 유전자들이 생물학적으로 어떤 관계가 있는지 알기가 어렵다. 본 연구에서는 유전자 발현량 데이터를 이미지 형태로 변환하여 예후 예측이 효과적으로 특징 선택 및 예후 예측을 수행할 수 있는 기법을 제안한다. 유전자들 사이의 생물학적 상호작용 관계를 유전자 발현량 데이터에 통합하기 위해 Node2Vec을 활용하였으며, 2차원 이미지로 표현된 발현량 데이터를 효과적으로 학습할 수 있도록 합성곱 신경망 모델을 사용하였다. 제안하는 모델의 성능은 이중 교차검증을 통해 평가되었고, 유전자 발현량 데이터를 그대로 이용하는 기계학습모델보다 우월한 예후 예측 정확도를 가지는 것이 확인되었다. Node2Vec을 이용한 유전자 발현량의 새로운 이미지 표현법은 특징 선택으로 인한 정보의 손실이 없어 예측 모델의 성능을 높일 수 있으며, 이러한 접근법이 개인 맞춤형 의학의 발전에 이바지할 것으로 기대한다.

• Journal of Information Processing Systems
• /
• 제19권5호
• /
• pp.673-687
• /
• 2023

Convolutional neural network-based deep learning technology is the most commonly used in image identification, but it requires large-scale data for training. Therefore, application in specific fields in which data acquisition is limited, such as in the military, may be challenging. In particular, the identification of ground weapon systems is a very important mission, and high identification accuracy is required. Accordingly, various studies have been conducted to achieve high performance using small-scale data. Among them, the ensemble method, which achieves excellent performance through the prediction average of the pre-trained models, is the most representative method; however, it requires considerable time and effort to find the optimal combination of ensemble models. In addition, there is a performance limitation in the prediction results obtained by using an ensemble method. Furthermore, it is difficult to obtain the ensemble effect using models with imbalanced classification accuracies. In this paper, we propose a transfer learning-based feature fusion technique for heterogeneous models that extracts and fuses features of pre-trained heterogeneous models and finally, fine-tunes hyperparameters of the fully connected layer to improve the classification accuracy. The experimental results of this study indicate that it is possible to overcome the limitations of the existing ensemble methods by improving the classification accuracy through feature fusion between heterogeneous models based on transfer learning.

• Asian Pacific Journal of Cancer Prevention
• /
• 제13권8호
• /
• pp.4113-4117
• /
• 2012

Breast cancer is a prevalent heterogeneous malignant disease. Gene expression profiling by DNA microarray can classify breast tumors into five different molecular subtypes: luminal A, luminal B, HER-2, basal and normal-like which have differing prognosis. Recently it has been shown that immunohistochemistry (IHC) markers including estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (Her2), can divide tumors to main subtypes: luminal A (ER+; PR+/-; HER-2-), luminal B (ER+;PR+/-; HER-2+), basal-like (ER-;PR-;HER2-) and Her2+ (ER-; PR-; HER-2+). Some subtypes such as basal-like subtype have been characterized by poor prognosis and reduced overall survival. Due to the importance of the ER signaling pathway in mammary cell proliferation; it appears that epigenetic changes in the $ER{\alpha}$ gene as a central component of this pathway, may contribute to prognostic prediction. Thus this study aimed to clarify the correlation of different IHC-based subtypes of breast tumors with $ER{\alpha}$ methylation in Iranian breast cancer patients. For this purpose one hundred fresh breast tumors obtained by surgical resection underwent DNA extraction for assessment of their ER methylation status by methylation specific PCR (MSP). These tumors were classified into main subtypes according to IHC markers and data were collected on pathological features of the patients. $ER{\alpha}$ methylation was found in 25 of 28 (89.3%) basal tumors, 21 of 24 (87.5%) Her2+ tumors, 18 of 34 (52.9%) luminal A tumors and 7 of 14 (50%) luminal B tumors. A strong correlation was found between $ER{\alpha}$ methylation and poor prognosis tumor subtypes (basal and Her2+) in patients (P<0.001). Our findings show that $ER{\alpha}$ methylation is correlated with poor prognosis subtypes of breast tumors in Iranian patients and may play an important role in pathogenesis of the more aggressive breast tumors.